$42.69
2.18% yesterday
NYSE, Dec 24, 09:30 pm CET
ISIN
US62548M1009
Symbol
CTEV

Claritev Stock price

$42.69
-5.41 11.25% 1M
+2.13 5.25% 6M
+27.91 188.84% YTD
+30.45 248.77% 1Y
-4.91 10.32% 3Y
-314.51 88.05% 5Y
-346.11 89.02% 10Y
-346.11 89.02% 20Y
NYSE, Closing price Wed, Dec 24 2025
+0.91 2.18%
ISIN
US62548M1009
Symbol
CTEV

Key metrics

Basic
Market capitalization
$705.5m
Enterprise Value
$5.3b
Net debt
$4.6b
Cash
$39.2m
Shares outstanding
16.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.7 | 0.7
EV/Sales
5.6 | 5.4
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
1.6%
Return on Equity
-1,958.8%
ROCE
1.0%
ROIC
-
Debt/Equity
-45.5
Financials (TTM | estimate)
Revenue
$951.0m | $979.2m
EBITDA
$492.0m | $614.3m
EBIT
$49.5m | $49.3m
Net Income
$-341.7m | $-273.2m
Free Cash Flow
$-112.2m
Growth (TTM | estimate)
Revenue
0.9% | 5.2%
EBITDA
-11.8% | 15.7%
EBIT
-61.1% | -50.2%
Net Income
77.8% | 83.4%
Free Cash Flow
-327.2%
Margin (TTM | estimate)
Gross
74.7%
EBITDA
51.7% | 62.7%
EBIT
5.2%
Net
-35.9% | -27.9%
Free Cash Flow
-11.8%
More
EPS
$-20.7
FCF per Share
$-6.8
Short interest
8.5%
Employees
-
Rev per Employee
-
Show more

Is Claritev a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.

Claritev Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Claritev forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Claritev forecast:

Buy
89%
Hold
11%

Financial data from Claritev

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
951 951
1% 1%
100%
- Direct Costs 240 240
1% 1%
25%
711 711
2% 2%
75%
- Selling and Administrative Expenses 219 219
52% 52%
23%
- Research and Development Expense - -
-
-
492 492
12% 12%
52%
- Depreciation and Amortization 442 442
3% 3%
47%
EBIT (Operating Income) EBIT 50 50
61% 61%
5%
Net Profit -342 -342
78% 78%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Claritev directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Claritev Stock News

Neutral
Seeking Alpha
23 days ago
Claritev Corporation (CTEV) Presents at Bank of America Leveraged Finance Conference Transcript
Neutral
Business Wire
about one month ago
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Participation at Upcoming Conferences.
Neutral
Business Wire
about one month ago
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”),...
More Claritev News

Company Profile

MultiPlan Corp. provides healthcare cost management solutions. It uses technology-enabled provider network, negotiation, claim pricing and payment accuracy services as building blocks for medical and dental payors to customize the healthcare cost management programs. The company was founded in 1980 and is headquartered in New York, NY.

Head office United States
CEO Travis Dalton
Founded 1980
Website www.claritev.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today